Pharmacists’ Regard Grows For OTCs As Rx Alternatives, APhA Officer Says
This article was originally published in The Tan Sheet
Executive Summary
Both pharmacists and consumers are paying increasing attention to the use of some OTCs as a solution to the Medicare Part D "coverage gap," according to Timothy L. Tucker, president-elect of the American Pharmacists Association
You may also be interested in...
FDA Plans Behind-The-Counter Drugs Meeting, Mulls “Transitional” Status
FDA will discuss the idea of behind-the-counter drug sales as a possible transitional stage between Rx and OTC status when it holds a forum on the topic with stakeholders
Expensive Rx Drugs Put Spotlight On OTC Opportunity – Economist
Over-the-counter drug firms have a promising opportunity to market their products as alternatives to Rx drugs for consumers confronted with coverage gaps in Medicare Part D and private insurance plans, a Princeton University economics and public affairs professor advised industry executives
Plan B Pioneers OTC “Pharmacy Counter” Approval, Dual-Status Marketing
FDA's decision to approve emergency contraceptive Plan B for over-the-counter sale to women age 18 and older cracks open the door on a pharmacy-only, behind-the-counter model for nonprescription drug sales